Here's how PUBMED.NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

PUBMED . NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Pubmed.ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://pubmed.ncbi.nlm.nih.gov/15850986/.

Title:
Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423 - PubMed
Description:
Bz-423 is a 1,4-benzodiazepine that suppresses disease in lupus-prone mice by selectively killing pathogenic lymphocytes, and it is less toxic compared to current lupus drugs. Cells exposed to Bz-423 rapidly generate O(2)(-) within mitochondria, and this reactive oxygen species is the signal initiat …
Website Age:
27 years and 8 months (reg. 1997-10-02).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is pubmed.ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Pubmed.ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of pubmed.ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Pubmed.ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Pubmed.ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

doi, pmid, mitochondrial, drug, pmc, oscp, free, article, inhibitors, proteins, ffatpase, target, glick, mitochondria, synthase, articles, mesh, opipari, oligomycin, protein, epub, atp, oct, metabolism, antagonists, pharmacology, effects, main, ncbi, similar, cited, related, resources, chem, biol, apr, jchembiol, molecular, johnson, swenson, lymphocytes, lupus, cells, inhibition, rna, pubmed, aug, sci, nih, adenosine,

Topics {✒️}

oligomycin sensitivity-conferring protein main page content promising anti-lupus drug mitochondrial dysfunction-related diseases molecular drug evaluation mitochondrial atp synthase mitochondrial f1f0-atpase mitochondrial atp synthesis mesh keyword united states government reactive oxygen species resources chem biol literature sources pubchem substance grants mitochondrial megachannel resides proton conductance proton channel funding linkout extramural research support related polyphenols mitochondria bz-423 rapidly generate oligomycin axis reagents lupus erythematosus similar articles cited molecular target lupus-prone mice current lupus drugs signal initiating apoptosis reconstitution experiments demonstrated pharmacol exp ther permeability transition pore opipari aw jr rna interference acs chem biol bovine f1-atpase reduced oscp expression sensitivity potential therapeutic target bz-423 binds bz-423 inhibited mechanistic basis mitochondrial hhs therapeutic targeting opipari jr life sci chem biol f1fo-atpase lupus therapeutics

External Links {🔗}(70)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • jQuery

CDN Services {📦}

  • Ncbi

3.18s.